Mal-amido-(CH2COOH)2 is an intermediate used for the synthesis of hydrophilic ADC linkers containing a maleimide ethyl group; it serves as a cleavable linker component in antibody-drug conjugates (ADCs), enabling lysosomal protease-mediated cleavage of dipeptide-based doxorubicin (DOX) conjugates after internalization of the immunoconjugates.